Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

COVID-19: Daily Top 10 Papers

  Prostate Cancer

  Free Subscription

Articles published in Am J Clin Oncol

Retrieve available abstracts of 28 articles:
HTML format

Single Articles

    February 2021
  1. PALY JJ, Egleston BL, Wong JK, Burbure N, et al
    Patient-reported Quality of Life After SBRT, LDR, and HDR Brachytherapy for Prostate Cancer: A Comparison of Outcomes.
    Am J Clin Oncol. 2021 Feb 9. pii: 00000421-900000000-98595.
    PubMed     Abstract available

    December 2020
  2. WU S, Lin SX, Wirth GJ, Lu M, et al
    Long-term Oncologic Impact of Positive Anterior and Posterior Surgical Margins After Radical Prostatectomy.
    Am J Clin Oncol. 2020;43:872-879.
    PubMed     Abstract available

  3. JANZEN BW, Ong A, Penner M, Koul R, et al
    Population-based Assessment of Intermittent Androgen Deprivation Therapy Utilization for Relapsed, Nonmetastatic, Hormone-sensitive Adenocarcinoma of the Prostate.
    Am J Clin Oncol. 2020;43:865-871.
    PubMed     Abstract available

    September 2020
  4. D'AGOSTINO GR, Mancosu P, Di Brina L, Franzese C, et al
    Stereotactic Body Radiation Therapy for Intermediate-risk Prostate Cancer With VMAT and Real-time Electromagnetic Tracking: A Phase II Study.
    Am J Clin Oncol. 2020;43:628-635.
    PubMed     Abstract available

    July 2020
  5. MURALIDHAR V, Dee EC, D'Amico AV
    Sequencing Treatments for Cancer During the COVID-19 Pandemic.
    Am J Clin Oncol. 2020;43:457-458.

    June 2020
  6. LEHRER S, Rheinstein PH
    Alzheimer Gene BIN1 may Simultaneously Influence Dementia Risk and Androgen Deprivation Therapy Dosage in Prostate Cancer.
    Am J Clin Oncol. 2020 Jun 19. doi: 10.1097/COC.0000000000000727.
    PubMed     Abstract available

  7. D'AGOSTINO GR, Mancosu P, Di Brina L, Franzese C, et al
    Stereotactic Body Radiation Therapy for Intermediate-risk Prostate Cancer With VMAT and Real-time Electromagnetic Tracking: A Phase II Study.
    Am J Clin Oncol. 2020 Jun 2. doi: 10.1097/COC.0000000000000721.
    PubMed     Abstract available

    April 2020
  8. PARSAI S, Juloori A, Sedor G, Reddy CA, et al
    Heterogenous Dose-escalated Prostate Stereotactic Body Radiation Therapy for All Risk Prostate Cancer: Quality of Life and Clinical Outcomes of an Institutional Pilot Study.
    Am J Clin Oncol. 2020 Apr 28. doi: 10.1097/COC.0000000000000693.
    PubMed     Abstract available

    February 2020
  9. ADDO-TABIRI NO, Chudasama R, Vasudeva R, Leiva O, et al
    Black Patients Experience Highest Rates of Cancer-associated Venous Thromboembolism.
    Am J Clin Oncol. 2020;43:94-100.
    PubMed     Abstract available

    January 2020
  10. LIU Z, Zhang T, Ma Z, Zheng S, et al
    Systemic Management for Nonmetastatic Castration-resistant Prostate Cancer: A Systematic Review and Network Meta-Analysis.
    Am J Clin Oncol. 2020 Jan 17. doi: 10.1097/COC.0000000000000660.
    PubMed     Abstract available

    December 2019
  11. VIANI GA, Arruda CV, Hamamura AC, Faustino AC, et al
    Stereotactic Body Radiotherapy for Oligometastatic Prostate Cancer Recurrence: A Meta-analysis.
    Am J Clin Oncol. 2019 Dec 4. doi: 10.1097/COC.0000000000000635.
    PubMed     Abstract available

    November 2019
  12. SYED S, Basourakos SP, Ali FS, Garcia JL, et al
    A Limited-Versus-Extensive Staging Strategy for Small Cell Prostate Cancer.
    Am J Clin Oncol. 2019 Nov 21. doi: 10.1097/COC.0000000000000631.
    PubMed     Abstract available

    October 2019
  13. IARROBINO NA, Gill B, Sutera PA, Kalash R, et al
    Early Exploratory Analysis for Patient-reported Quality of Life and Dosimetric Correlates in Hypofractionated Stereotactic Body Radiation Therapy (SBRT) for Low-risk and Intermediate-risk Prostate Cancer: Interim Results from a Prospective Phase II Cl
    Am J Clin Oncol. 2019 Oct 3. doi: 10.1097/COC.0000000000000586.
    PubMed     Abstract available

  14. ASAMOAH FA, Yarney J, Awasthi S, Vanderpuye V, et al
    Definitive Radiation Treatment Patterns and Outcomes for Low and Intermediate Risk Prostate Cancer Patients: A Cross-Continental Comparative Study.
    Am J Clin Oncol. 2019 Oct 3. doi: 10.1097/COC.0000000000000589.
    PubMed     Abstract available

    August 2019
  15. HUO J, Bian J, Xie Z, Hong YR, et al
    Patterns of Postdiagnosis Depression Among Late-Stage Cancer Patients: Do Racial/Ethnic and Sex Disparities Exist?
    Am J Clin Oncol. 2019;42:675-681.
    PubMed     Abstract available

    April 2019
  16. TAKU N, Narayan V, Wang X, Vapiwala N, et al
    Prevalence, Predictors, and Implications for Appropriate Use of Active Surveillance Management Among Black Men Diagnosed With Low-risk Prostate Cancer.
    Am J Clin Oncol. 2019 Apr 29. doi: 10.1097/COC.0000000000000547.
    PubMed     Abstract available

    March 2019
  17. DEN RB, George D, Pieczonka C, McNamara M, et al
    Ra-223 Treatment for Bone Metastases in Castrate-Resistant Prostate Cancer: Practical Management Issues for Patient Selection.
    Am J Clin Oncol. 2019 Mar 4. doi: 10.1097/COC.0000000000000528.
    PubMed     Abstract available

    February 2019
  18. STEIN MN, Chen YH, Carducci MA, Hudes GR, et al
    Phase II Trial of Eribulin in Patients With Metastatic Hormone Refractory Prostate Cancer: A Trial of the ECOG-ACRIN Cancer Research Group (E5805).
    Am J Clin Oncol. 2019 Feb 15. doi: 10.1097/COC.0000000000000526.
    PubMed     Abstract available

  19. FOSTER B, Jackson W, Foster C, Dess R, et al
    Application of a Prognostic Stratification System for High-risk Prostate Cancer to Patients Treated With Radiotherapy: Implications for Treatment Optimization.
    Am J Clin Oncol. 2019 Feb 4. doi: 10.1097/COC.0000000000000521.
    PubMed     Abstract available

    January 2019
  20. RICE SR, Olexa G, Hussain A, Mannuel H, et al
    A Phase II Study Evaluating Bone Marrow-Sparing, Image-guided Pelvic Intensity-Modulated Radiotherapy (IMRT) With Cesium-131 Brachytherapy Boost, Adjuvant Chemotherapy, and Long-Term Hormonal Ablation in Patients With High Risk, Nonmetastatic Prostate
    Am J Clin Oncol. 2019 Jan 22. doi: 10.1097/COC.0000000000000520.
    PubMed     Abstract available

    September 2018
  21. WALE DJ, Viglianti BL, Gross MD, Ferretti A, et al
    Nuclear Medicine Therapy With 223Radium-dichloride for Osseous Metastases in Prostate Carcinoma.
    Am J Clin Oncol. 2018 Sep 10. doi: 10.1097/COC.0000000000000479.
    PubMed     Abstract available

    April 2018
  22. SATKUNASIVAM R, Lo M, Stern M, Gill IS, et al
    The Role of Provider Characteristics in the Selection of Surgery or Radiation for Localized Prostate Cancer and Association With Quality of Care Indicators.
    Am J Clin Oncol. 2018 Apr 17. doi: 10.1097/COC.0000000000000442.
    PubMed     Abstract available

    March 2018
  23. J BLEDSOE T, S Park H, E Rutter C, Aneja S, et al
    Impact of Health Insurance Status on Prostate Cancer Treatment Modality Selection in the United States.
    Am J Clin Oncol. 2018 Mar 7. doi: 10.1097/COC.0000000000000423.
    PubMed     Abstract available

    January 2018
  24. TRAN S, Jorcano S, Falco T, Lamanna G, et al
    Oligorecurrent Nodal Prostate Cancer: Long-term Results of an Elective Nodal Irradiation Approach.
    Am J Clin Oncol. 2018 Jan 8. doi: 10.1097/COC.0000000000000419.
    PubMed     Abstract available

  25. KANG JJ, Reiter RE, Kummer N, DeKernion J, et al
    Wrong to be Right: Margin Laterality is an Independent Predictor of Biochemical Failure After Radical Prostatectomy.
    Am J Clin Oncol. 2018;41:1-5.
    PubMed     Abstract available

    December 2017
  26. YING J, Wang CJ, Yan J, Liauw SL, et al
    Long-term Outcome of Prostate Cancer Patients Who Exhibit Biochemical Failure Despite Salvage Radiation Therapy After Radical Prostatectomy.
    Am J Clin Oncol. 2017;40:612-620.
    PubMed     Abstract available

  27. LAWRENCE YR, Samueli B, Levitin R, Pail O, et al
    Do Prostate Cancer Patients With Markedly Elevated PSA Benefit From Radiation Therapy?: A Population-based Study.
    Am J Clin Oncol. 2017;40:605-611.
    PubMed     Abstract available

    May 2017
  28. SHAVERDIAN N, Kishan AU, Veruttipong D, Demanes DJ, et al
    Impact of the Primary Information Source Used for Decision Making on Treatment Perceptions and Regret in Prostate Cancer.
    Am J Clin Oncol. 2017 May 23. doi: 10.1097/COC.0000000000000387.
    PubMed     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Prostate Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.